Alb	Serum albumin
AXL	AXL receptor tyrosine kinase
BOR	Best overall response
Cabo	Cabozantinib
CI	Confidence interval
CRP	C-reactive protein
Δ	Change from baseline
HR	Hazard ratio
ICI	Immune checkpoint inhibitor
IMDC	International Metastatic RCC Database Consortium
KM	Kaplan–Meier
LDH	Lactate dehydrogenase
mRCC	Metastatic renal cell carcinoma
NLR	Neutrophil-to-lymphocyte ratio
PFS	Progression-free survival
RDI	Relative dose intensity
SII	Systemic immune–inflammation index
TKI	Tyrosine kinase inhibitor
TRAE	Treatment-related adverse event